Delivery Order SPE2DX22D0089-SPE2D826F0D99

This delivery order, awarded on October 20, 2025, represents a $37,570.40 firm fixed-price contract issued by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) for pharmaceutical and medical supply products. The contract, which is not set-aside and was competitively awarded, is classified as a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. Performance will be completed by October 21, 2025, with work performed at the company's corporate office location in Conshohocken, Pennsylvania.

AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies a comprehensive range of medical products to support military and veteran healthcare systems, including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. As a prime contractor under the DLA's Pharmaceutical Prime Vendor program, the company leverages its extensive distribution network to fulfill federal medical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order continues AmerisourceBergen's established role in supporting the department's global pharmaceutical supply chain operations.